drugset / Trial / NCT07258173
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Phase 2
Not yet recruiting
100 enrolled
Jennifer Keiser
Bayer · collabCentre Suisse de Recherches Scientifiques en Cote d'Ivoire · collabUniversité Félix Houphouët-Boigny · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this clinical trial is to compare the efficacy and safety of emodepside with the standard treatment, albendazole, in adolescents (12 years and older) and adults infected with Trichuris incognita.
Timeline
- Start
- 2026-05-15
- Primary completion
- 2026-09-15
- Completion
- 2026-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albendazole | Small molecule | 400 mg | — |
| Subject | Emodepside | Small molecule | 15 mg | — |